Phosphodiesterase inhibitors have differential effects on placental versus decidual prorenin release.
Poisner
A M
AM
Department of Pharmacology, University of Kansas Medical Center, Kansas City 66160.
Downing
G J
GJ
Poisner
R
R
D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D002823:Chorion / Q000378:metabolism; D003470:Culture Media; D003656:Decidua / Q000187:drug effects / Q000378:metabolism*; D004792:Enzyme Precursors / Q000378:metabolism*; D005321:Extraembryonic Membranes / Q000187:drug effects / Q000378:metabolism; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D010920:Placenta / Q000187:drug effects / Q000378:metabolism*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011247:Pregnancy; D015363:Quinolones / Q000494:pharmacology; D012083:Renin / Q000378:metabolism*
D003470:Culture Media; D004792:Enzyme Precursors; D010726:Phosphodiesterase Inhibitors; D010975:Platelet Aggregation Inhibitors; D015363:Quinolones; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; C021294:cilostamide; D012083:Renin